Cargando…

Metabolic changes during exclusive enteral nutrition in pediatric Crohn’s disease patients

BACKGROUND AND AIMS: Exclusive enteral nutrition is recommended as a first-line treatment in active pediatric Crohn’s Disease, but its mechanism of action is still not clear. We aimed to assess alterations in the metabolic profile of newly diagnosed pediatric Crohn’s Disease patients before and duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Jair G., Schwerd, Tobias, Bufler, Philip, Koletzko, Sibylle, Koletzko, Berthold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700625/
https://www.ncbi.nlm.nih.gov/pubmed/36434414
http://dx.doi.org/10.1007/s11306-022-01953-0
_version_ 1784839352147247104
author Marques, Jair G.
Schwerd, Tobias
Bufler, Philip
Koletzko, Sibylle
Koletzko, Berthold
author_facet Marques, Jair G.
Schwerd, Tobias
Bufler, Philip
Koletzko, Sibylle
Koletzko, Berthold
author_sort Marques, Jair G.
collection PubMed
description BACKGROUND AND AIMS: Exclusive enteral nutrition is recommended as a first-line treatment in active pediatric Crohn’s Disease, but its mechanism of action is still not clear. We aimed to assess alterations in the metabolic profile of newly diagnosed pediatric Crohn’s Disease patients before and during exclusive enteral nutrition therapy. METHODS: Plasma samples from 14 pediatric Crohn’s Disease patients before and after 3–4 weeks on exclusive enteral nutrition were analyzed using mass spectrometry. T-test, fold change and orthogonal partial least squares discriminant analysis were used for mining significant features. Correlation analysis was performed between the annotated features and the weighted pediatric Crohn’s disease activity index using Pearson r distance. RESULTS: Among the 13 compounds which decreased during exclusive enteral nutrition, most are related to diet, while one is a bacterial metabolite, Bacteriohopane-32,33,34,35-tetrol. The phosphatidic acid metabolite PA(15:1/18:0) was significantly reduced and correlated with the weighted pediatric Crohn’s disease activity index. Lipids increased during exclusive enteral nutrition therapy included phosphatidylethanolamines; PE(24:1/24:1), PE(17:2/20:2) and one lactosylceramide; LacCer(d18:1/14:0). CONCLUSION: Food additives and other phytochemicals were the major metabolites, which decreased following the exclusion of a regular diet during exclusive enteral nutrition. An alteration in bacterial biomarkers may reflect changes in intestinal microbiota composition and metabolism. Thus, metabolomics provides an opportunity to characterize the molecular mechanisms of dietary factors triggering Crohn’s Disease activity, and the mechanisms of action of exclusive enteral nutrition, thereby providing the basis for the development and evaluation of improved intervention strategies for prevention and treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11306-022-01953-0.
format Online
Article
Text
id pubmed-9700625
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-97006252022-11-27 Metabolic changes during exclusive enteral nutrition in pediatric Crohn’s disease patients Marques, Jair G. Schwerd, Tobias Bufler, Philip Koletzko, Sibylle Koletzko, Berthold Metabolomics Original Article BACKGROUND AND AIMS: Exclusive enteral nutrition is recommended as a first-line treatment in active pediatric Crohn’s Disease, but its mechanism of action is still not clear. We aimed to assess alterations in the metabolic profile of newly diagnosed pediatric Crohn’s Disease patients before and during exclusive enteral nutrition therapy. METHODS: Plasma samples from 14 pediatric Crohn’s Disease patients before and after 3–4 weeks on exclusive enteral nutrition were analyzed using mass spectrometry. T-test, fold change and orthogonal partial least squares discriminant analysis were used for mining significant features. Correlation analysis was performed between the annotated features and the weighted pediatric Crohn’s disease activity index using Pearson r distance. RESULTS: Among the 13 compounds which decreased during exclusive enteral nutrition, most are related to diet, while one is a bacterial metabolite, Bacteriohopane-32,33,34,35-tetrol. The phosphatidic acid metabolite PA(15:1/18:0) was significantly reduced and correlated with the weighted pediatric Crohn’s disease activity index. Lipids increased during exclusive enteral nutrition therapy included phosphatidylethanolamines; PE(24:1/24:1), PE(17:2/20:2) and one lactosylceramide; LacCer(d18:1/14:0). CONCLUSION: Food additives and other phytochemicals were the major metabolites, which decreased following the exclusion of a regular diet during exclusive enteral nutrition. An alteration in bacterial biomarkers may reflect changes in intestinal microbiota composition and metabolism. Thus, metabolomics provides an opportunity to characterize the molecular mechanisms of dietary factors triggering Crohn’s Disease activity, and the mechanisms of action of exclusive enteral nutrition, thereby providing the basis for the development and evaluation of improved intervention strategies for prevention and treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11306-022-01953-0. Springer US 2022-11-25 2022 /pmc/articles/PMC9700625/ /pubmed/36434414 http://dx.doi.org/10.1007/s11306-022-01953-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Marques, Jair G.
Schwerd, Tobias
Bufler, Philip
Koletzko, Sibylle
Koletzko, Berthold
Metabolic changes during exclusive enteral nutrition in pediatric Crohn’s disease patients
title Metabolic changes during exclusive enteral nutrition in pediatric Crohn’s disease patients
title_full Metabolic changes during exclusive enteral nutrition in pediatric Crohn’s disease patients
title_fullStr Metabolic changes during exclusive enteral nutrition in pediatric Crohn’s disease patients
title_full_unstemmed Metabolic changes during exclusive enteral nutrition in pediatric Crohn’s disease patients
title_short Metabolic changes during exclusive enteral nutrition in pediatric Crohn’s disease patients
title_sort metabolic changes during exclusive enteral nutrition in pediatric crohn’s disease patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700625/
https://www.ncbi.nlm.nih.gov/pubmed/36434414
http://dx.doi.org/10.1007/s11306-022-01953-0
work_keys_str_mv AT marquesjairg metabolicchangesduringexclusiveenteralnutritioninpediatriccrohnsdiseasepatients
AT schwerdtobias metabolicchangesduringexclusiveenteralnutritioninpediatriccrohnsdiseasepatients
AT buflerphilip metabolicchangesduringexclusiveenteralnutritioninpediatriccrohnsdiseasepatients
AT koletzkosibylle metabolicchangesduringexclusiveenteralnutritioninpediatriccrohnsdiseasepatients
AT koletzkoberthold metabolicchangesduringexclusiveenteralnutritioninpediatriccrohnsdiseasepatients